Intuitive Surgical Stock Rises on Strong Q3 Earnings and South Korean Approval

The company's shares surged nearly 7% following a better-than-expected financial performance and regulatory clearance for its da Vinci 5 system.

Intuitive Surgical reported an adjusted earnings of $1.84 per share, surpassing forecasts of $1.64.
The company's revenue increased by 17% to $2.04 billion, exceeding expectations of $2.01 billion.
Procedure growth for Intuitive's da Vinci systems reached 18%, slightly above the predicted 17.6%.
Intuitive Surgical received regulatory clearance in South Korea for its next-generation da Vinci 5 surgical system.
The stock has risen over 40% this year, with analysts optimistic about future demand for the da Vinci 5.